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Background:  Uncorrected patent ductus arteriosus (PDA) can cause irreversible pulmonary hypertension (PH) with development of 
Eisenmenger syndrome. Balloon occlusion establishes reversible PH. If balloon occlusion is impractical, vasodilator challenge with inhaled 
nitric oxide (INO) can demonstrate reversible PH and candidacy for PDA closure if pulmonary artery pressure (PAP) and pulmonary 
vascular resistance (PVR) fall. However, in large PDA, INO causes pulmonary vasodilation, increases left-to-right shunt flow, and maintains 
elevated PAP and PVR. Since PAP and PVR appear fixed, these patients may incorrectly be classified with irreversible PH and unsuitable 
for PDA closure.
case:   A 39-year-old Hispanic woman complained of dyspnea with minimal exertion. Precordial palpation revealed a thrill. S2 was split with 
an accentuated P2, and a grade 4/6 continuous murmur was heard in the left infraclavicular region. There was no cyanosis or clubbing. 
Transthoracic echocardiogram revealed a large PDA and severe PH with a PAP of 140.7 mmHg.
decision Making:  The patient underwent right and left heart catheterization with unsuccessful PDA balloon occlusion due to its large 
size and flow. INO caused minimal reduction in PAP and PVR, consistent with fixed PH. However, pulmonary artery oxygen saturation 
increased from 89.6% to 98.4%, equal to systemic oxygen saturation. This suggested increased shunt flow and reversible PH. A 16 mm 
Amplatzer muscular VSD occluder was deployed across the PDA. PAP fell from 68 to 35 mmHg and PVR fell from 9.4 to 4.88 Wood units. 
Post-closure, the patient reported marked improvement in dyspnea. Six months later she underwent repeat right heart catheterization that 
demonstrated a PAP of 39 mmHg.
conclusion:  ACC/AHA guidelines recommend against PDA closure if PH is severe and irreversible. If the PDA is too large for balloon 
occlusion, vasodilator challenge may cause no significant decrease in PAP and PVR, leading to the false conclusion that PH is irreversible 
and PDA closure is contraindicated. This case highlights the importance of assessing shunt flow with vasodilator challenge in these 
patients, for an increase in flow suggests reversible PH and suitability for PDA closure.
